Healthcare Financial News

Fresh from its $838 million takeover of aged care operator Estia Health, Bain Capital is back for another piece of the pie.

The S&P BSE Sensex fell over 100 points, while the Nifty50 closed below 19,800 levels. Sectorally, buying was seen in auto, realty, and healthcare stocks while profit-taking was seen in banks, IT, metal, and the public sector. Stocks that were in focus include names like ITI, which was up by about 20%, HDFC Asset Management Company, which rose more than 3%, and Angel One, which pared gains after hitting an all-time high in trade on Friday to end in the red. We have collated a list of three stocks that either hit a fresh 52-week high, or all-time high or saw a volume or a price breakout. We spoke to an analyst on how one should look at these stocks the next trading day entirely from an educational point of view: Analyst: Sunil Gurjar, Founder Chartmojo, Author, CFTe ITI (All-Time High) The stock has been going up in great momentum, and on the daily time frame, it seems to be forming up trend continuation patterns and giving breakout from the same. If you look at Friday’s breakout candle, then it has taken the formation of bullish Marubozu candlestick, which is signifying a strong upside from hereon. One should keep Friday's breakout candle as an invalidation level. 21- EMA is a short-term trend identification moving average that signals that the stock is in strong upside momentum. HDFC AMC (52-Week high) The counter has been trading above all the key moving averages’ which seems to suggest that it is poised for a big run in the forthcoming trading session. The counter has given a pattern breakout with strong volume buildup as well, signalling big hands are also taking part in the stock. The breakout candle will act as an invalidation level for the bullish position and trail the trading position with the

By Anirban Sen and Mrinmay Dey

ALSO READ: Govt’s mental health helpline helped over 350,000 people He said strengthening medical, nursing, and pharmacy education in the country is an endeavour of the BJP-led Centre for the holistic development and expansion of the country's health sector. "The aim is to ensure that each citizen of India can get access to affordable and accessible healthcare across the country," the minister said.

Mansukh Mandaviya on Saturday inaugurated Nagaland's first medical college — the Nagaland Institute of Medical Sciences & Research (NIMSR). Mandaviya unveiled the monolith marking the inauguration, in the presence of Chief Minister Neiphiu Rio, Deputy CM TR Zeliang, state ministers, MLAs and bureaucrats. The college has 100 seats — 85 for students of Nagaland and 15 for other states. Addressing the function, Mandaviya said that the first medical college of the state will not only impart medical education but it will also be a research centre. The central government under the leadership of Prime Minister Narendra Modi wants to set up healthcare facilities in every part of the country, he said. Medical and nursing education needs to be strengthened considering the need of the hour, he added. There were about 64,000 MBBS seats in the country in 2014, and it has increased manifold, Mandaviya said. «Similarly PG seats have also doubled in the last nine years,» he said. He asked the Nagaland government to start Jan Aushadi Kendras in every health facility of the state, and assured full support of the Centre. CM Rio said it was a historic day for the people of Nagaland as their dream of a medical college was fulfilled. The state has a severe shortage of doctors, and there are shortcomings in the delivery of secondary and tertiary levels of healthcare, he said. He said that he hoped the new facility would grow into a centre of excellence. Rio urged the people to ensure special care and love for the students coming from other states to study at NIMSR, so that they become the ambassadors of the state.

cervical cancer cases diagnosed between 2012 and 2015 survived, scientists have found after analysing data from Population Based Cancer Registries (PBCRs) across India. Ahmedabad's urban PBCR had a higher survival rate of 61.5 per cent followed by Thiruvananthapuram (58.8 per cent) and Kollam (56.1 per cent). Tripura had the lowest survival rate of 31.6 per cent, the researchers said in their study published in the journal The Lancet Regional Health Southeast Asia. A total of 5591 cervical cancer cases from 11 PBCRs diagnosed between 2012 and 2015 were studied.

By Moira Warburton

1. Max Performer - Best Sexual Enhancement Pills Overall 2. Ultraload - Top Pills for Better Ejaculation, Increased semen volume 3. Prime male - Best to Increase Sex Drive 4. VigRX Plus - Top Erection Pills 5. Prosolution Plus - Best Sex Pills to Last Longer in Bed Click HERE to find the Max Performer at the lowest price online Max Performer is produced by a reputable and well-known supplement company that provides natural and effective sexual enhancement solutions for men.

Unions representing 75,000 health care workers who recently held a strike against industry giant Kaiser Permanente over wages and staffing shortages have reached a tentative agreement with the company

(Reuters) — U.S. equity funds suffered substantial outflows in the week ending Oct. 11, driven by concerns over persistent higher U.S. interest rates and escalating geopolitical tensions in the Middle East.

Check out what's clicking on FoxBusiness.com

Laurus Labs on Friday said it has received approval from Indian drug regulator the Central Drugs Standard Control Organization (CDSCO) for its CAR-T cell therapy NexCAR19 (actalycabtagene autoleucel), for the treatment of certain types of blood cancers. NexCAR19 will be the first humanized CD19-targeted Chimeric Antigen Receptor T cell (CAR-T) therapy indigenously developed in India to be approved.

Naukri’s JobSpeak index. The index grew at 6% month-on-month in September 2023 but fell by 8.6% from a year ago, which shows a dip in overall hiring since the highs of 2022. Within the sectors that hired the most, hospitality, travel grew by 22%, and BFSI and healthcare grew by 7% each, according to the data. Oil and gas, and auto were the other areas that saw growth. Drilling down into the growth sectors Hospitality and travel were in the positive territory as monsoon season, festive season and the upcoming winter season led to a spurt in travel this time of the year. Both solo travellers and families are travelling more.

Relative Strength Index (RSI), a technical indicator that provides valuable insights into a stock's momentum and potential price movements. RSI can be a game-changer for investors looking to make informed decisions. The Relative Strength Index, or RSI, is a momentum oscillator that measures the speed and change of price movements. It ranges from 0 to 100 and is typically used to identify overbought or oversold conditions in a stock. Here's how it works: An RSI above 70 indicates that a stock may be overbought, suggesting that it could be due for a price correction. An RSI below 30 suggests that a stock may be oversold, hinting at a potential price increase. Exploring 10 Stocks with Rising RSI On October 12, StockEdge reported that 39 stocks were experiencing a surge in RSI, indicating strong momentum.

₹2.8 lakh crore. Sustained infrastructure investments shall help the capital goods, industrials, and infrastructure sectors to continue performing in the coming months. Auto and auto ancillary sectors shall also continue to see selective traction as a few sub-segments in the industry are performing extremely well and with the upcoming festive season, the momentum is expected to continue.

gseb.org. The Class 10 and Class 12 Science stream exams will end on 22 March while Class 12 General stream will end on 26 March.

Hamas has made an urgent plea to international relief organisations to deliver essential medical and humanitarian supplies to Gaza, where Israel's ongoing airstrikes have exacerbated a deepening humanitarian crisis, CNN reported. The region faces the risk of starvation and the imminent depletion of fuel resources as Israel has withheld critical supplies in response to Hamas' recent acts of violence. Hamas issued a statement, urging «all relief, health, and charitable institutions in the Arab, Islamic, and international communities to swiftly provide necessary medical and humanitarian aid, as well as fuel, to save the lives of over two million Palestinian residents.» Palestinian Minister of Health Mai Alkaila also warned of an imminent healthcare system collapse in Gaza due to severe shortages of medical equipment, surgical supplies, medications, and blood bags. Norwegian Minister of Foreign Affairs Anniken Huitfeldt expressed strong disapproval of a complete blockade, which would deny access to electricity, water, food, and essential goods necessary for civilian survival in Gaza. She emphasised that Israel has a responsibility to permit humanitarian aid access and ensure assistance for the civilian population.

medical devices can continue to import and manufacture the devices for another six months if they have applied for licences, the government said on Thursday, providing a major relief to the industry. The Central Drugs Standard Control Organisation (CDSCO) had set the October 1 deadline for bringing ‘class C’ and ‘class D’ medical devices under regulation as part of quality control efforts. To obtain the licences several manufacturers had submitted applications, but the government failed to provide them on time.

Tens of millions of older Americans will see a modest increase in benefits in January when a new cost-of-living adjustment is added to Social Security payments

While a few companies have already reported results, it is safe to say that the Q3 2023 earnings season will only kick into high gear tomorrow, spearheaded by major U.S. banks. Against a backdrop of economic uncertainty, high interest rates, subdued consumer confidence, and geopolitical tensions stemming from the Israel-Hamas conflict, investors could certainly use some good news.

Revenue from operations during the period rose 8% to Rs 26,672 crore as against Rs 24,686 crore in the same period last year. The board has declared an interim dividend of Rs 12 per equity share for the financial year 2023-24. The record date for the same has been fixed as October 20 and the payment will be on October 31. Both profit and revenue were above the estimates.